PMV Pharmaceuticals, Inc.

In the quarter to June 2026, EPS grew 17.1% and free cash flow grew 20.3%, each against the same quarter a year earlier.

1.21 0.08 −6.20%

Follow PMVP

Alert me

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(51.87%)	(55.37%)	(63.16%)	(70.93%)
ROA Full definition →		(46.29%)	(50.51%)	(58.65%)	(64.04%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(68.69%)	(74.72%)	(89.65%)	(105.95%)
Free Cash Flow per Share Full definition →		(1.37)	(1.40)	(1.41)	(1.33)
Free Cash Flow Full definition →		(72.87)	(73.57)	(74.99)	(71.26)
Capital Expenditures Full definition →		0.18	0.00	—	—
Other line items
Cash ROIC Full definition →		(29.12%)	(33.80%)	(41.31%)	(47.22%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		(0.03)	(0.03)	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.88	0.95	0.96	0.95
Depreciation/Fixed assets Full definition →		(12.75)	(11.13)	(10.77)	(12.03)
Capex/Depreciation Full definition →		(0.06)	0.00	0.00	0.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(1.38)	(1.40)	(1.41)	(1.33)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	—	—

Columns are period end dates